Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01670487 · ClinicalTrials.gov registry record · NA

Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients

A NA study of Pain, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT01670487: Completed NA study of Pain, sponsored by The Cleveland Clinic.

NCT01670487 is a NA study of Pain that has completed, run by The Cleveland Clinic. The registered enrollment target is 300 participants, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01670487, a NA study of Pain, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

To determine the efficacy and safety of vapocoolant stream (Pain Ease Medium Stream ) in decreasing the pain of intravenous cannulation. To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water) stream.

Primary Outcome

Numeric rating scale (NRS) 0-10 : 0 (no pain) - 5 (moderate pain) - 10 (worst pain). Scores to be utilized after stream device applied and after intravenous catheter placement.

Conditions Studied

Interventions

  • DEVICE Vapocoolant
  • DEVICE Sterile water

Study Locations (1)

Ohio

  • The Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2012-10
Est. Completion 2014-12
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT01670487 record still lists

NCT01670487 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Vapocoolant is the first listed.

NCT01670487 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01670487 about?

NCT01670487 is a clinical study titled "Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients". To determine the efficacy and safety of vapocoolant stream (Pain Ease Medium Stream ) in decreasing the pain of intravenous cannulation. To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water) stream.

What is the current status of trial NCT01670487?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2012-10. Estimated completion is 2014-12.

What conditions does trial NCT01670487 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01670487?

The interventions under investigation include: Vapocoolant (DEVICE), Sterile water (DEVICE).

Who is sponsoring clinical trial NCT01670487?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01670487 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01670487's enrollment target sits among peer trials

300 57th of 374 higher than 315 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01670487, the US trial registry maintained by the National Library of Medicine. NCT01670487 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.